IDEX Corporation (IEX) Stock Price & How to Invest

IDEX Corporation is an applied solutions company that designs and manufactures highly engineered pumps, flow meters, valves, fluidic systems, and other components used to move and measure fluids. It operates across three reporting segments: Health & Science Technologies (precision fluidics, optics, and sealing for life science, analytical instruments, and semiconductors), Fluid & Metering Technologies (industrial pumps, metering, and water and wastewater equipment), and Fire & Safety/Diversified Products (rescue tools, fire suppression components, and dispensing equipment). Its products are typically small pieces of larger customer systems where reliability matters more than price, which supports pricing power and recurring aftermarket demand.

The investment picture is a classic serial-compounder story. IDEX generates strong margins and free cash flow from a broad portfolio of niche, market-leading product lines, and it reinvests through a steady cadence of bolt-on acquisitions that expand its addressable markets. Q1 2026 net sales rose about 9% to roughly $887 million with record orders near $988 million and adjusted EBITDA margins around 26%, prompting raised full-year guidance. The trade-off is that this consistency is well recognized by the market, so the stock carries a premium industrial multiple that leaves less room for disappointment if end markets soften or acquisitions underperform.

IDEX is exposed to broad industrial cyclicality, and softness in chemical and certain short-cycle end markets has periodically offset strength elsewhere. Its acquisition-driven model carries integration and capital-allocation risk, and paying too much for deals or misjudging end markets could dilute returns. The stock trades at a premium industrial multiple (trailing P/E in the low 30s), so any growth or margin disappointment could compress the valuation. Currency swings, supply chain costs, and demand tied to customer capital spending in life science and semiconductors add variability. A slowdown in global manufacturing or infrastructure investment would pressure organic growth.

14 analysts publish price targets on IEX, averaging $248.43 against a $230.45 price as of August 2026, or +7.8%. The published targets run from $210.00 to $280.00, a narrow spread, and the ratings split 8 buy, 7 hold, 0 sell. Over the last six months there have been 11 raises and 1 cut among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full IEX forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on IDEX Corporation. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Health & Science Technologies momentum. The Health & Science Technologies segment has been the standout, with organic revenue up roughly 11% and record orders in Q1 2026, led by life science, analytical instruments, and semiconductor-related fluidics. The most optimistic published target, $280.00, assumes this works close to its best case.

The case against. IDEX is exposed to broad industrial cyclicality, and softness in chemical and certain short-cycle end markets has periodically offset strength elsewhere. The most pessimistic target, $210.00, is roughly what IEX is worth if this bites instead.

Read the full bull and bear case on IEX, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see IDEX Corporation's investor relations page or your broker.

• Revenue (TTM): ~$3.4B
• Q1 2026 net sales: ~$887M (+9% YoY)
• Q1 2026 orders: ~$988M (record, +13%)
• Adjusted EBITDA margin: ~26%
• Market cap: ~$16.5B
• Trailing P/E: ~33x

As of July 2026 IEX traded around $224 with a market cap near $16.5 billion and a trailing P/E in the low 30s, a premium typical of high-quality, acquisitive industrials. The valuation reflects consistent margins, record orders, and raised guidance, but it also leaves limited cushion if end markets weaken. The dividend yield sits near 1.3%, with the company having raised its payout for more than 15 consecutive years.

If you want IEX exposure as part of a larger bundle rather than directly, these ETFs hold it meaningfully. Weights are approximate and refresh quarterly.

Other names that sit close to IEX: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get IEX exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it (FIW, PHO), which spreads the position across many companies. Or build it into a focused thematic portfolio, so IEX sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where IEX fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

IEX is a well-run, acquisitive fluidics and flow-control compounder whose appeal rests on consistent margins and disciplined M&A, weighed against a valuation that already prices in that quality.

Whether IEX is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is IEX a buy or a sell?, and where the stock could go from here in the IEX stock forecast.

For income investors, whether IEX pays a dividend and how the payout looks is covered in does IEX pay a dividend? And to weigh IEX against a peer, read the full side-by-side comparisons: IEX vs DOV and IEX vs ROP.